Literature DB >> 23433300

The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy.

T H Hung1, C J Lay, C M Chang, J J Tsai, C C Tsai, C C Tsai.   

Abstract

Cirrhotic patients are prone to having infections, which may aggravate hepatic encephalopathy (HE). However, the effect of infections on mortality in HE cirrhotic patients is not well described. The National Health Insurance Database, derived from the Taiwan National Health Insurance Programme, was used to identify 4150 adult HE cirrhotic patients hospitalized between 1 January 2004 and 31 December 2004. Nine hundred and eighty-five patients (23.7%) had one or more co-existing infections during their hospitalization. After Cox proportional hazard regression modelling adjusted by the patients' gender, age, and medical comorbidity disorders, the hazard ratios (HRs) in HE patients with infections for 30-day, 30- to 90-day, and 90-day to 1-year mortalities were 1.66 [95% confidence interval (CI) 1.42-1.94], 1.51 (95% CI 1.23-1.85) and 1.34 (95% CI 1.13-1.58), respectively. Compared to the non-infection group, the HRs of pneumonia, spontaneous bacterial peritonitis, urinary tract infection, sepsis without specific focus (SWSF), cellulitis, and biliary tract infection were 2.11, 1.48, 1.06, 2.21, 1.06, and 0.78, respectively, for 30-day mortality; 1.82, 1.22, 0.93, 2.24, 0.31, and 2.82, respectively, for 30- to 90-day mortality; and 2.03, 0.82, 1.24, 1.64, 1.14, and 0.60, respectively, for 90-day to 1-year mortality for HE cirrhotic patients. We conclude that infections increase the mortality of HE cirrhotic patients, especially pneumonia and SWSF.

Entities:  

Mesh:

Year:  2013        PMID: 23433300      PMCID: PMC9151375          DOI: 10.1017/S0950268813000186

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  32 in total

1.  Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.

Authors:  Mónica Guevara; María E Baccaro; Jose Ríos; Marta Martín-Llahí; Juan Uriz; Luis Ruiz del Arbol; Ramón Planas; Alberto Monescillo; Carlos Guarner; Javier Crespo; Rafael Bañares; Vicente Arroyo; Pere Ginès
Journal:  Liver Int       Date:  2010-06-29       Impact factor: 5.828

2.  Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Christine M Schubert; Douglas M Heuman; James B Wade; Douglas P Gibson; Allyne Topaz; Kia Saeian; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Melanie B White; Arun J Sanyal
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

Review 3.  Severe sepsis in cirrhosis.

Authors:  Thierry Gustot; François Durand; Didier Lebrec; Jean-Louis Vincent; Richard Moreau
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

4.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

5.  Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock.

Authors:  Won Young Kim; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Crit Care       Date:  2011-06-28       Impact factor: 3.425

Review 6.  Bacterial infections in liver cirrhosis.

Authors:  M Navasa; J Fernández; J Rodés
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-10

Review 7.  Pathogenetic mechanisms of hepatic encephalopathy.

Authors:  D Häussinger; F Schliess
Journal:  Gut       Date:  2008-08       Impact factor: 23.059

8.  Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.

Authors:  N Udayakumar; K Subramaniam; L Umashankar; Joy Verghese; V Jayanthi
Journal:  J Clin Gastroenterol       Date:  2007 Nov-Dec       Impact factor: 3.062

9.  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Authors:  Oliviero Riggio; Stefania Angeloni; Filippo Maria Salvatori; Adriano De Santis; Federica Cerini; Alessio Farcomeni; Adolfo Francesco Attili; Manuela Merli
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

10.  The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury.

Authors:  P R Knight; G Druskovich; A R Tait; K J Johnson
Journal:  Anesthesiology       Date:  1992-10       Impact factor: 7.892

View more
  12 in total

Review 1.  [Anesthesia with liver failure].

Authors:  Eva-Lotte Camboni-Schellenberg; Barbara Sinner
Journal:  Anaesthesist       Date:  2016-01       Impact factor: 1.041

2.  Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy.

Authors:  Claude V Dennis; Pamela J Sheahan; Manuel B Graeber; Donna L Sheedy; Jillian J Kril; Greg T Sutherland
Journal:  Metab Brain Dis       Date:  2013-12-19       Impact factor: 3.584

Review 3.  What we know: the inflammatory basis of hepatic encephalopathy.

Authors:  K Milewski; M Oria
Journal:  Metab Brain Dis       Date:  2015-10-26       Impact factor: 3.584

4.  Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients.

Authors:  Krystal T Sood; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2019-01-24

5.  Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Kuo-Chih Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

6.  MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy.

Authors:  Valérie Martel-Laferrière; Caitlin Homberger; Kian Bichoupan; Douglas T Dieterich
Journal:  BMC Gastroenterol       Date:  2014-10-17       Impact factor: 3.067

7.  The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chorng-Jang Lay; Chih-Wei Tseng; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

8.  High Mortality of Cirrhotic Patients With End-Stage Renal Disease.

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Kuo-Chih Tseng; Chih -Wei Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Hsing-Feng Lee
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.

Authors:  Tsung-Hsing Hung; Chih-Ming Liang; Chien-Ning Hsu; Wei-Chen Tai; Kai-Lung Tsai; Ming-Kun Ku; Jiunn-Wei Wang; Kuo-Lun Tseng; Lan-Ting Yuan; Seng-Howe Nguang; Shih-Cheng Yang; Cheng-Kun Wu; Pin-I Hsu; Deng-Chyang Wu; Seng-Kee Chuah
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

10.  CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.

Authors:  Jin Hee Jeong; In Sung Park; Dong Hoon Kim; Seong Chun Kim; Changwoo Kang; Soo Hoon Lee; Tae Yun Kim; Sang Bong Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.